A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g
NCT00096603
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
450
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
Raptiva (efalizumab)
Sponsor
Genentech, Inc.